Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

509

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Filgotinib

Sponsor

Alfasigma S.p.A.